BAX
BAXTER INTERNATIONAL INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 23 ▲ Michael McCaul bought $15,001 - $50,000, last disclosed Apr 10
- May 1 to May 27 ▲ 3 buys: Ro Khanna bought $1,001 - $15,000, last disclosed Jun 11
- Jun 11 ▼ A mixed institutional cluster in BAX for Q3 2025 shows 7 buyers addi…
- Jun 16 United States v. Baxter
- Jul 30 ▲ Baxter reported Q2 2026 results that significantly exceeded consensu…
- Aug 14 ▲ Short interest falls 26.8% to 23.91M
- Sep 17 Wynn v. Baxter et al
- Sep 28 to Sep 29 2 court rulings: Williams v. Baxter; Baxter v. PDD Holdings Inc. et al
- Oct 7 Barclays initiates
- Oct 19 HICKS v. BAXTER et al
- Oct 29 ▲ Baxter reported Q3 2026 revenue of $2.976B, up 5% YoY, and adjusted…
- Oct 29 ▲ Earnings: BAX Q3 2026 Earnings: EPS $0.58 (+10.9% vs est)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q2 2026: 46 added (1 new), 21 trimmed or exited. Largest new: Holocene Advisors $56.8M.
- AnalystsMIXED
5 of 20 rate it Buy or better. Median target $26.00 (+2%).
- Short sellersSTEADY
Short interest −0.4% to 23.67M shares. 3.0 days to cover, ≈4.6% of shares.
- TrendUPTREND
4% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $203.2M |
| GOLDMAN SACHS GROUP INC | ADD | $152.4M |
| MARSHALL WACE, LLP | DOUBLED | $103.6M |
| NORGES BANK | TRIM | $88.4M |
| Holocene Advisors, LP | NEW | $56.8M |
| JONES FINANCIAL COMPANIES LLLP | ADD | $53.0M |
| Artisan Partners Limited Partnership | NEAR_EXIT | $21.8M |
| Gotham Asset Management, LLC | DOUBLED | $18.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analystsPrice is inside the target range. Median implies +2%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Barclays MAINTAIN | Underweight |
| Oct 30, 2026 | JP Morgan MAINTAIN | Neutral |
| Oct 30, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 7, 2026 | Barclays INITIATE | Underweight |
| Oct 5, 2026 | Citigroup MAINTAIN | Neutral |
| Jul 31, 2026 | TD Cowen MAINTAIN | Hold |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Hider Andrew P. President and CEO Sep 2, 2026 | TAX W/H | $1.4M |
Foster Julie President, Front Line Care Sep 2, 2026 | TAX W/H | $53.9K |
Teaff James President, CCS Sep 1, 2026 | TAX W/H | $19.1K |
Wallace Steven P. President, Adv. Surgery Jun 2, 2026 | TAX W/H | $2.9K |
Teaff James President, CCS Jun 2, 2026 | TAX W/H | $6.0K |
Zielinski Anita A SVP, Interim CFO, CAO & Cntrlr Jun 1, 2026 | AWARD | 13,426 sh |
MORRISON PATRICIA Director May 5, 2026 | AWARD | 12,836 sh |
SCHLICHTING NANCY M Director May 5, 2026 | AWARD | 12,836 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
15 filings · 4 bullish · 1 bearish · 2 mixed · 8 neutral- BULLISH 8-KOct 29, 2026
Baxter reported Q3 2026 revenue of $2.976B, up 5% YoY, and adjusted EPS of $0.58, down 16% YoY due…
The raised guidance and strong Q3 beat on EPS suggest improving operational momentum, but the YoY decline in adjusted EPS and the FDA warning letter on Novum IQ LVP are risks to monitor. Watch for…
- NEUTRAL SC 13G/AOct 27, 2026
BlackRock Portfolio Management LLC filed an amended Schedule 13G disclosing beneficial ownership…
BlackRock's passive stake remains stable at 5.9%. No change in position or intent. Monitor for any future conversion to a Schedule 13D, which would signal activist intent, but no such indication…
- NEUTRAL INST-CLUSTEROct 23, 2026
Three small asset managers increased their BAX positions in Q3 2026, with aggregate holdings…
The buying is small in scale and comes from routine asset managers, not informed or activist capital. Monitor next quarter's 13F for larger or more concentrated institutional moves, but this cluster…
- NEUTRAL 8-KAug 19, 2026
Baxter appointed John Rogers as CFO, effective October 1, 2026, replacing departing interim CFO…
Monitor the Q3 2026 earnings release for any changes to the full-year 2026 outlook under the new CFO. The leadership transition is orderly and not a catalyst for near-term trading.
All BAX filing & press-release reports (15)
- 8-K reportOct 29, 2026
- SC 13G/A reportOct 27, 2026
- INST-CLUSTER reportOct 23, 2026
- 8-K reportAug 19, 2026
- 8-K reportAug 18, 2026
- INST-CLUSTER reportAug 12, 2026
- 8-K reportAug 4, 2026
- 8-K reportJul 30, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 8, 2026
- 8-K reportApr 30, 2026
- DEFA14A reportApr 29, 2026
- COURT-RULING reportMar 4, 2026
- DEFA14A reportMar 23, 2026
- INST-CLUSTER reportFeb 28, 2026